Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Biosciences
Cambridge, MA, USAmdbneuro.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
MD Biosciences does not report clinical results as it does not develop its own drugs. Instead, it provides preclinical and translational contract research services to pharmaceutical and biotechnology clients to help advance their therapies into the clinic using advanced large animal models and innovative methodologies.
- Therapeutic areas
- DermatologyImmunologyNeurology
- Modalities
- Small moleculeBiologicDevice
- Industry
- Contract Research Organization
02
Partnerships
Participates in collaborative efforts such as RPG in pain management/researchsupports academic collaborations advancing animal welfare
Beyond the preview
Go deeper on MD Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MD Biosciences.